Achilles Tendinopathy After Treatment with Ophthalmic Moxifloxacin

REFERENCES

1. 1.↵
   1. Tanne JH

   . FDA adds “black box” warning label to fluoroquinolone antibiotics. BMJ 2008;337:a816.

   OpenUrlFREE Full Text
2. 2.↵
   1. Khaliq Y,
   2. Zhanel GG

   . Fluoroquinolone-associated tendinopathy: A critical review of the literature. Clin Infect Dis 2003;36:1404–10.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Movin T,
   2. Gad A,
   3. Guntner P,
   4. Foldhazy Z,
   5. Rolf C

   . Pathology of the Achilles tendon in association with ciprofloxacin treatment. Foot Ankle Int 1997;18:297–9.

   OpenUrlPubMed
4. 4.↵
   1. Hall MM,
   2. Finnoff JT,
   3. Smith J

   . Musculoskeletal complications of fluoroquinolones: Guidelines and precautions for usage in the athletic population. PM R 2011;3:132–42.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Williams RJ 3rd.,
   2. Attia E,
   3. Wickiewicz TL,
   4. Hannafin JA

   . The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am J Sports Med 2000;28:364–9.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Corps AN,
   2. Harrall RL,
   3. Curry VA,
   4. Fenwick SA,
   5. Hazleman BL,
   6. Riley GP

   . Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1-beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum 2002;46:3034–40.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Pouzaud F,
   2. Bernard-Beaubois K,
   3. Thevenin M,
   4. Warnet JM,
   5. Hayem G,
   6. Rat P

   . In vitro discrimination of fluoroquinolones toxicity on tendon cells: Involvement of oxidative stress. J Pharmacol Exp Ther 2004;308:394–402.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Clode AB,
   2. Davis JL,
   3. Salmon J,
   4. LaFevers H,
   5. Gilger BC

   . Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses. Am J Vet Res 2010;71:564–9.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Kim GK

   . The risk of fluoroquinolone-induced tendinopathy and tendon rupture: What does the clinician need to know? J Clin Aesthet Dermatol 2010;3:49–54.

   OpenUrlPubMed